{"name":"Fundació Privada Eugin","slug":"fundaci-privada-eugin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Clomifene Citrate","genericName":"Clomifene Citrate","slug":"clomifene-citrate","indication":"Anovulation and oligoovulation in women seeking pregnancy","status":"marketed"},{"name":"Progevera","genericName":"Progevera","slug":"progevera","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Clomifene Citrate","genericName":"Clomifene Citrate","slug":"clomifene-citrate","phase":"marketed","mechanism":"Clomifene citrate is a selective estrogen receptor modulator that blocks negative feedback of estrogen on the hypothalamic-pituitary-ovarian axis, thereby increasing gonadotropin secretion to stimulate ovulation.","indications":["Anovulation and oligoovulation in women seeking pregnancy","Male infertility due to low testosterone or oligospermia"],"catalyst":""},{"name":"Progevera","genericName":"Progevera","slug":"progevera","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}